Varenicline as compared to bupropion in smoking-cessation therapy—Cost–utility results for Sweden 2003
- 1 May 2008
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 102 (5) , 699-710
- https://doi.org/10.1016/j.rmed.2007.12.018
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the NetherlandsCurrent Medical Research and Opinion, 2007
- Smoking, healthcare cost, and loss of productivity in Sweden 2001Scandinavian Journal of Public Health, 2007
- Varenicline for Smoking CessationPublished by American Medical Association (AMA) ,2006
- Effect of Maintenance Therapy With Varenicline on Smoking CessationA Randomized Controlled TrialJAMA, 2006
- Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking CessationA Randomized Controlled TrialJAMA, 2006
- Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking CessationA Randomized Controlled TrialJAMA, 2006
- The Cost Utility of Bupropion in Smoking Cessation Health ProgramsChest, 2006
- Development of the health and economic consequences of smoking interactive modelTobacco Control, 2001
- The economic impact of smoking in Germany.European Respiratory Journal, 2000
- The Mortality of Doctors in Relation to Their Smoking HabitsBMJ, 1954